Contrasting actions of prolonged mitogen-activated protein kinase activation on cell survival

被引:5
作者
Badrian, Bahareh [1 ]
Casey, Tammy M. [1 ]
Lai, May C. [1 ]
Rakoczy, P. Elizabeth [1 ]
Arthur, Peter G. [1 ]
Bogoyevitch, Marie A. [1 ]
机构
[1] Univ Western Australia, Lions Eye Inst, Crawley, WA 6009, Australia
基金
英国医学研究理事会;
关键词
mitogen-activated protein kinase; cell death; energy stress; ATP levels; superoxide dismutase;
D O I
10.1016/j.bbrc.2006.04.161
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Activation of the ERK mitogen-activated protein kinase pathway has been implicated in pro-survival and cellular protective mechanisms. so that chronic ERK activation may be a useful therapeutic strategy. Here, we further explored the consequences of prolonged ERK activation following expression of constitutively active form of MEK, MEK-EE, in cardiac myocytes. We confirmed that chronic MEK-EE overexpression halved myocyte death following glucose deprivation, but surprisingly this was not associated with preserved intracellular ATP levels. Whilst activities of a number of antioxidant enzymes were not altered upon MEK-EE expression, paradoxically Cu/Zn superoxide dismutase activity was almost halved upon MEK-EE expression. When we then exposed myocytes to the superoxide generator menadione, we observed significantly higher death of MEK-EE expressing myocytes. Pre-incubation with U0126 inhibited menadione-induced death. Our results are the first to show that MEK-ERK signalling can act to increase or decrease cell survival., the outcome depending on the form of stress stimulus encountered. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:843 / 850
页数:8
相关论文
共 43 条
[1]
Subcellular localization determines the protective effects of activated ERK2 against distinct apoptogenic stimuli in myeloid leukemia cells [J].
Ajenjo, N ;
Cañón, E ;
Sánchez-Pérez, I ;
Matallanas, D ;
León, J ;
Perona, R ;
Crespo, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (31) :32813-32823
[2]
MEK1 protein kinase inhibition protects against damage resulting from focal cerebral ischemia [J].
Alessandrini, A ;
Namura, S ;
Moskowitz, MA ;
Bonventre, JV .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (22) :12866-12869
[3]
Comparison of in vitro preconditioning responses of isolated pig and rabbit cardiomyocytes: Effects of a protein phosphatase inhibitor, fostriecin [J].
Armstrong, SC ;
Kao, R ;
Gao, W ;
Shivell, LC ;
Downey, JM ;
Honkanen, RE ;
Ganote, CE .
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1997, 29 (11) :3009-3024
[4]
The protective effect of hypoxic preconditioning on cortical neuronal cultures is associated with increases in the activity of several antioxidant enzymes [J].
Arthur, PG ;
Lim, SCC ;
Meloni, BP ;
Munns, SE ;
Chan, A ;
Knuckey, NW .
BRAIN RESEARCH, 2004, 1017 (1-2) :146-154
[5]
AUTOMATED-ANALYSIS OF CELLULAR METABOLITES AT NANOMOLAR TO MICROMOLAR CONCENTRATIONS USING BIOLUMINESCENT METHODS [J].
ARTHUR, PG ;
HOCHACHKA, PW .
ANALYTICAL BIOCHEMISTRY, 1995, 227 (02) :281-284
[6]
Cardioprotective effects of transforming growth factor-β1 during early reoxygenation or reperfusion are mediated by p42/p44 MAPK [J].
Baxter, GF ;
Mocanu, MM ;
Brar, BK ;
Latchman, DS ;
Yellon, DM .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2001, 38 (06) :930-939
[7]
Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy [J].
Bogoyevitch, MA ;
Andersson, MB ;
GillespieBrown, J ;
Clerk, A ;
Glennon, PE ;
Fuller, SJ ;
Sugden, PH .
BIOCHEMICAL JOURNAL, 1996, 314 :115-121
[8]
MARKED REDUCTION OF FREE-RADICAL GENERATION AND CONTRACTILE DYSFUNCTION BY ANTIOXIDANT THERAPY BEGUN AT THE TIME OF REPERFUSION - EVIDENCE THAT MYOCARDIAL STUNNING IS A MANIFESTATION OF REPERFUSION INJURY [J].
BOLLI, R ;
JEROUDI, MO ;
PATEL, BS ;
ARUOMA, OI ;
HALLIWELL, B ;
LAI, EK ;
MCCAY, PB .
CIRCULATION RESEARCH, 1989, 65 (03) :607-622
[9]
Urocortin protects against ischemic and reperfusion injury via a MAPK-dependent pathway [J].
Brar, BK ;
Jonassen, AK ;
Stephanou, A ;
Santilli, G ;
Railson, J ;
Knight, RA ;
Yellon, DM ;
Latchman, DS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (12) :8508-8514
[10]
The MEK1-ERK1/2 signaling pathway promotes compensated cardiac hypertrophy in transgenic mice [J].
Bueno, OF ;
De Windt, LJ ;
Tymitz, KM ;
Witt, SA ;
Kimball, TR ;
Klevitsky, R ;
Hewett, TE ;
Jones, SP ;
Lefer, DJ ;
Peng, CF ;
Kitsis, RN ;
Molkentin, JD .
EMBO JOURNAL, 2000, 19 (23) :6341-6350